Novel and potent MICA/B antibody is therapeutically effective in KRAS LKB1 mutant lung cancer models is a research paper published in Journal for ImmunoTherapy of Cancer (2025). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Prevention and Research Institute of Texas
Grant: DP240248
Cancer Prevention and Research Institute of Texas
Grant: RR160080
National Cancer Center Network
Grant: YIA2021
National Institutes of Health
Grant: 5P50CA070907
National Institutes of Health
Grant: P30CA142543
National Institutes of Health
Grant: R01CA276058
National Institutes of Health
Grant: R01CA289500
National Institutes of Health
Grant: T32CA124334
Congressionally Directed Medical Research Programs
Grant: W81XWH-21-1-0856
FWCI
3.24
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals